Kymera Therapeutics
KYMR
#4059
Rank
โ‚ฌ2.05 B
Marketcap
31,58ย โ‚ฌ
Share price
2.75%
Change (1 day)
-18.20%
Change (1 year)

Kymera Therapeutics (KYMR) - Cash on Hand

Cash on Hand as of December 2024 : โ‚ฌ0.44 Billion

According to Kymera Therapeutics's latest financial reports the company has โ‚ฌ0.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Kymera Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.46 B38.5%
2023-12-31โ‚ฌ0.33 B-10.66%
2022-12-31โ‚ฌ0.37 B-2.83%
2021-12-31โ‚ฌ0.39 B62.22%
2020-12-31โ‚ฌ0.24 B193.37%
2019-12-31โ‚ฌ82.08 M127.6%
2018-12-31โ‚ฌ36.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.23 B-47.63%๐Ÿ‡บ๐Ÿ‡ธ USA